Exact Mass: 395.0884662
Exact Mass Matches: 395.0884662
Found 152 metabolites which its exact mass value is equals to given mass value 395.0884662,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Novobiocic acid
C22H21NO6 (395.13688060000004)
A hydroxycoumarin that is the aglycone of novobiocin.
Gonyautoxin II
Gonyautoxin III is found in mollusks. Gonyautoxin III is from Gonyaulax and Protogonyaulax species. From Gonyaulax and Protogonyaulax subspecies Gonyautoxin II is found in mollusks. D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
Toxin b2
D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
Gonyautoxin VI
Gonyautoxin VI is found in mollusks. Gonyautoxin VI is produced by Gonyaulax and Protogonyaulax species, isolated from shellfish. Neurotoxin; causal agent with Saxitoxin, of shellfish poisoning. Production by Gonyaulax and Protogonyaulax subspecies, isolated from shellfish. Neurotoxin; causal agent with Saxitoxin, of shellfish poisoning. Gonyautoxin VI is found in mollusks.
Oxaliplatin
Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. Oxaliplatin is marketed by Sanofi-Aventis under the trademark Eloxatin®.
1,1-Diphenyl-2-picrylhydrazine
C18H13N5O6 (395.08657980000004)
2,5-Dimethylcelecoxib
C18H16F3N3O2S (395.09152720000003)
Balaglitazone
C20H17N3O4S (395.09397220000005)
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent Balaglitazone is a selective partial PPARγ agonist with an EC50 of 1.351 μM for human PPARγ.
5-Pyrimidinecarboxylic acid, 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro-2-pyridinyl)-1,4-dihydro-6-methyl-, methyl ester, (4R)-
C18H13ClF3N3O2 (395.06483440000005)
Guanidine, N-(4-chlorophenyl)-N'-cyano-N'-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)-, trans-
Imidodicarbonimidic diamide, N-(1-methylethyl)-N'-(3-(2,4,5-trichlorophenoxy)propoxy)-, hydrochloride
C14H20Cl3N5O2 (395.06825100000003)
M1
Basic protein, MW 5677 Da. A gamma-thionin showing antifungal activity. Isolated from seeds of yellow mustard, Sinapis alba. [CCD]. M1 is found in brassicas.
Benzomalvin C
C24H17N3O3 (395.12698520000004)
7-hydroxy-1-(1-hydroxyethyl)-8-methyl-2,3,8,9a,10,12a-hexahydro-6H-benzo[cd]furo[2,3:5,6]pyrano[3,4-g]pyrrolo[1,2-a]indole-6,11(1H)-dione
C22H21NO6 (395.13688060000004)
spiro[(5S)-3-methoxy-2-cyclopenten-1-one-5:3(2S)-2-chloro-3aS,7aS-((2,3)-1-methylpyrrolidine)-6,7-dimethoxy-1,2,3,3a,4,7a-hexahydro-4H,5H-inden-4,5-dione]
C19H22ClNO6 (395.11355820000006)
2-(4-hydroxybenzoyloxymethyl)-4-O-beta-D-glucopyranosyloxy-2(E)-butenenitrile|nigrumin-4-hydroxy-benzoate
4,9,10,11-tetramethoxy-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-8-one|Ocominaron|Ocominarone
5-[(6,7-Dimethoxyisoquinolin-1-yl)carbonyl]-1,3-benzodioxole-4-carboxylic acid methyl ester
3-Methyl-3-(6,7-dimethoxyisoquinoline-1-yl)-4,7-dimethoxyisobenzofuran-1(3H)-one
C22H21NO6 (395.13688060000004)
cardiospermin-5-(4-hydroxy) benzoate|Cardiospermin-5-(4-hydroxy)benzoate
3-(6,7-Dimethoxy-isoquinolin-1-yl)-3-(3,4-dimethoxy-phenyl)-acrylic acid
C22H21NO6 (395.13688060000004)
C24H17N3O3_Spiro[oxirane-2,7(13H)-quinazolino[3,2-a][1,4]benzodiazepine]-5,13(6H)-dione, 6-methyl-3-phenyl-, (2S,3S)
C24H17N3O3 (395.12698520000004)
(2S,3S)-6-methyl-3-phenylspiro[oxirane-2,7-quinazolino[3,2-a][1,4]benzodiazepine]-5,13-dione
C24H17N3O3 (395.12698520000004)
Cys Cys Gly Asn
Cys Cys Asn Gly
Cys Gly Cys Asn
Cys Gly Asn Cys
Cys Asn Cys Gly
Cys Asn Gly Cys
Gly Cys Cys Asn
Gly Cys Asn Cys
Gly Asn Cys Cys
Asn Cys Cys Gly
Asn Cys Gly Cys
Asn Gly Cys Cys
N-(4,7-Dihydroxy-8-methyl-2-oxo-2H-chromen-3-yl)-2,2-dimethylchromane-6-carboxamide
C22H21NO6 (395.13688060000004)
[4-(2,4-difluorophenyl)-2-[(2,5-dimethylphenyl)carbamoyl]phenyl] acetate
C23H19F2NO3 (395.13329280000005)
6-(3-chloropropoxy)-N- (3-chloro-4-fluorophenyl)-7-Methoxyquinazolin-4-aMine
C18H16Cl2FN3O2 (395.06035479999997)
tert-butyl 7-bromo-4-oxospiro[3H-chromene-2,4-piperidine]-1-carboxylate
C18H22BrNO4 (395.07321120000006)
3-(4-chlorophenyl)sulfanyl-4-ethylsulfonyl-7-methoxy-2-methyl-1H-indole
tert-Butyl ((diphenylphosphoryl)methyl)sulfonylcarbamate
C18H22NO5PS (395.09562520000003)
tert-Butyl 6-bromo-4-oxospiro[chroman-2,4-piperidine]-1-carboxylate
C18H22BrNO4 (395.07321120000006)
(R)-2-(((BENZYLOXY)CARBONYL)AMINO)BUTANE-1,4-DIYL DIMETHANESULFONATE
2-AMINO-5,7-DIPHENYL-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID EHYL ESTER
[4-(2,4-difluorophenyl)-2-(propylcarbamoyl)phenyl] benzoate
C23H19F2NO3 (395.13329280000005)
dea-c8-18 perfluoroalkylethyl phosphate
C10H20F6NO6P (395.09323820000003)
4-Benzyloxy-2-(2carbomethoxy)thiophenylnitrobenzene
C21H17NO5S (395.08273920000005)
(2R,3R,4S,5R)-2-(6-amino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol
C13H16F3N5O4S (395.08750520000007)
5-[3-(TERT-BUTYL)-1-(2,4-DICHLOROBENZYL)-1H-PYRAZOL-5-YL]-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL
C17H19Cl2N5S (395.07381540000006)
1-tert-Butyl 4-(pentafluorophenyl) piperidine-1,4-dicarboxylate
C17H18F5NO4 (395.11559280000006)
Imidodicarbonimidic diamide, N-(1-methylethyl)-N-(3-(2,4,5-trichlorophenoxy)propoxy)-, hydrochloride
C14H20Cl3N5O2 (395.06825100000003)
D007004 - Hypoglycemic Agents > D001645 - Biguanides
methyl 5-[(E)-(tert-butylcarbamothioylhydrazinylidene)methyl]-1-(2,4-difluorophenyl)pyrazole-4-carboxylate
(E)-2-Benzylidene-5-bromo-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one
2-(6-{[(3-Chloro-2-Methylphenyl)sulfonyl]amino}pyridin-2-Yl)-N,N-Diethylacetamide
C18H22ClN3O3S (395.10703320000005)
(2r,3r)-7-(Methylsulfonyl)-3-(2,4,5-Trifluorophenyl)-1,2,3,4-Tetrahydropyrido[1,2-A]benzimidazol-2-Amine
C18H16F3N3O2S (395.09152720000003)
1-[(1S)-Carboxy-2-(methylsulfinyl)ethyl]-(3R)-[(5S)-5-amino-5-carboxypentanamido]-(4R)-sulfanylazetidin-2-one
C13H21N3O7S2 (395.08208759999997)
(2,6-diamino-9,10,10-trihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methoxycarbonylsulfamic acid
Guanidine, N-(4-chlorophenyl)-N'-cyano-N'-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)-, trans-
Gonyautoxin 2
D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
Nogalaviketone(1-)
A phenolate anion obtained by deprotonation of the 5-OH group of nogalaviketone. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
4-[3-(3-Fluorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide
6-Amino-1,3-dimethyl-5-[(3-methyl-1-phenyl-5-thieno[2,3-c]pyrazolyl)-oxomethyl]pyrimidine-2,4-dione
2-(3-Chlorophenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester
C22H18ClNO4 (395.09242980000005)
5-[(2-Fluorophenyl)methyl]-6,11-dioxo-3-benzo[b][1,4]benzothiazepinecarboxylic acid
C21H14FNO4S (395.06275360000006)
4-(2,4-Dichlorophenoxy)butanoic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester
C19H19Cl2NO4 (395.06910740000006)
N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide
1-[4-Chloro-3-(4-morpholinylsulfonyl)phenyl]-3-phenylurea
C17H18ClN3O4S (395.07064980000007)
N-[6-(diethylsulfamoyl)-1,3-benzothiazol-2-yl]-2-thiophenecarboxamide
C16H17N3O3S3 (395.04320120000006)
2-[4-[(4-Chlorophenyl)methoxy]phenyl]-5-(4-morpholinyl)-4-oxazolecarbonitrile
C21H18ClN3O3 (395.10366280000005)
3-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-(5-methyl-2-thiazolyl)benzamide
C17H21N3O4S2 (395.09734260000005)
4-(2,4-dichlorophenoxy)-N-[(1E)-(3-nitrophenyl)methylene]butanohydrazide
C17H15Cl2N3O4 (395.04395700000003)
3-(3-Chloro-2-methylphenyl)-1-[(4-methylphenyl)methyl]-1-(3-pyridinylmethyl)thiourea
C22H22ClN3S (395.12228820000007)
2-(2-methoxyethyl)-9-methyl-1-oxo-N-(thiophen-2-ylmethyl)-4-pyrido[3,4-b]indolecarboxamide
C21H21N3O3S (395.13035560000003)
2-[[5-(6-methyl-1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(4-methyl-2-thiazolyl)acetamide
(5-Chloro-2-hydroxyphenyl)-[2-ethyl-3-(4-fluorophenyl)-6-pyrazolo[1,5-a]pyrimidinyl]methanone
2-[[5-(4-methylphenyl)-3-thiazolo[2,3-c][1,2,4]triazolyl]thio]-N-(6-methyl-2-pyridinyl)acetamide
3,6-Diamino-10-(3-carboxypropyl)acridinium perchlorate
Tetraethyl [(3-hydroxy-2-pyridyl)amino]methanediphosphonate
C15H27NO7P2 (395.12626919999997)
2-(Acetylamino)-4-O-[(4,5-didehydro-1-deoxy-beta-D-glucopyranuronic acid)-1-yl]-2-deoxy-D-glucopyranose
(2R,3R,4R)-2-[(3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
(2R,3R,4R)-2-[(2R,3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
(E)-3-(6,7-dimethoxyisoquinolin-1-yl)-3-(3,4-dimethoxyphenyl)prop-2-enoic acid
C22H21NO6 (395.13688060000004)
BE-54238B
C22H21NO6 (395.13688060000004)
An organic heterohexacyclic compound that is isolated from Streptomyces sp. A54238. It exhibits inhibitory efficacy against the growth of human tumour cells.
FASN-IN-1
C18H25N3O3S2 (395.13372599999997)
FASN-IN-1 is a fatty acid synthase (FASN) inhibitor extracted from patent WO2015134790A1, compound 56[1].
LY3020371 (hydrochloride)
C15H16ClF2NO5S (395.04057400000005)
LY3020371 hydrochloride is a potent, selective metabotropic glutamate 2/3 receptor (mGlu2/3) antagonist with Ki of 5.3 and 2.5 nM, potently blocks cAMP formation with IC50 of 16.2 nM[1]. LY3020371 hydrochloride exerts an antidepressant-like signature in vivo[2].
MMRi62
MMRi62, a ferroptosis inducer targeting MDM2-MDM4 (negative regulators of tumor suppressor p53). MMRi62 shows a P53-independent pro-apoptotic activity against pancreatic ductal adenocarcinoma (PDAC) cells and induce autophagy. MMRi62 inducesferroptosis, resulting in a increase of reactive oxygen and lysosomal degradation of ferritin heavy chain (FTH1). MMRi62 also leads to proteasomal degradation of mutant p53, also inhibits orthotopic xenograft PDAC mouse model in vivo with high frequency mutation characteristics of KRAS and TP53.12[1][2].
(2s,3r)-9'-methyl-3-phenyl-1',9',12'-triazaspiro[oxirane-2,10'-tetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadecane]-2',4',6',11',13',15',17'-heptaene-8',19'-dione
C24H17N3O3 (395.12698520000004)
[(2-{5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene}-1-hydroxy-2-phenylethylidene)amino]acetic acid
n-sulfo{[(3as,4r,10as)-5,10,10-trihydroxy-2,6-diimino-hexahydropyrrolo[1,2-c]purin-4-yl]methoxy}carboximidic acid
(2e)-2-cyano-2-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethylidene)ethyl 4-hydroxybenzoate
2-cyano-2-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethylidene)ethyl 4-hydroxybenzoate
11-hydroxy-20-(1-hydroxyethyl)-9-methyl-4,8-dioxa-21-azahexacyclo[10.9.1.0²,¹⁰.0³,⁷.0¹⁶,²².0¹⁷,²¹]docosa-1,10,12(22),14,16-pentaene-5,13-dione
C22H21NO6 (395.13688060000004)
12-[2-(dimethylamino)ethyl]-13,14-dimethoxy-3,5,16-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-1,6,8(18),9,11(19),12,14-heptaen-17-one
C22H21NO6 (395.13688060000004)